Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Structural Biology|March 1, 2006
Metal exposure and Alzheimer's pathogenesisGuijian Liu, Weidong Huang, Robert D Moir, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 7, 2017
Assessments of plasma ghrelin levels in the early stages of parkinson's diseaseNing Song, Weiwei Wang, Fengjv Jia, et al.
Annals of the New York Academy of Sciences|February 1, 2005
New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonistsNigel H Greig, Mark P Mattson, Tracyann Perry, et al.
The Journal of Biological Chemistry|June 22, 2005
The acute box cis-element in human heavy ferritin mRNA 5'-untranslated region is a unique translation enhancer that binds poly(C)-binding proteinsAndrew M Thomson, Catherine M Cahill, Hyun-Hee Cho, et al.
Scientific Reports|April 29, 2016
High-resolution analytical imaging and electron holography of magnetite particles in amyloid cores of Alzheimer's diseaseGermán Plascencia-Villa, Arturo Ponce, Joanna F Collingwood, et al.
Molecular Therapy. Nucleic Acids|June 19, 2017
Tat-haFGF<sub>14-154</sub> Upregulates ADAM10 to Attenuate the Alzheimer Phenotype of APP/PS1 Mice through the PI3K-CREB-IRE1α/XBP1 PathwayTian Meng, Qin Cao, Peng Lei, et al.
Current Alzheimer Research|July 18, 2006
RNA therapeutics directed to the non coding regions of APP mRNA, in vivo anti-amyloid efficacy of paroxetine, erythromycin, and N-acetyl cysteineStephanie Tucker, Michelle Ahl, Hyun-Hee Cho, et al.
Acta Neurobiologiae Experimentalis|June 12, 2004
Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseasesNigel H Greig, Tony Giordano, Xiaoxiang Zhu, et al.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry|January 31, 2013
Synthesis of the Alzheimer drug Posiphen into its primary metabolic products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their inhibition of amyloid precursor protein, α-Synuclein synthesis, interleukin-1β release, and cholinergic actionQian-Sheng Yu, Marcella Reale, Mohammad A Kamal, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 12, 2011
The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and PosiphenJack T Rogers, Sohan Mikkilineni, Ippolita Cantuti-Castelvetri, et al.
Pageof 7